Dr Joe Christopher, clinician scientist in Dr Raheleh Rahbari’s team at the Wellcome Sanger Institute, is contributing to efforts to uncover cancer at its earliest stages – guided by patients, driven by curiosity and built on the belief that the biggest breakthroughs come from working together.
Red, itchy, unpredictable – eczema is more than just a skincare issue. It is a chronic inflammatory condition that affects people’s day-to-day lives. We explore what it is, what remains unclear and how researchers at the Wellcome Sanger Institute are getting beneath the surface to find out more.
Cecilia Kyany’a studies the fascinating microbiology of the airway microbiome, especially in people living with cystic fibrosis. As part of her PhD research, Cecilia is uncovering the hidden microbial worlds that shape this complex condition.
Inflammatory bowel disease (IBD) looks different for everyone who has it. We spoke with medical student, Imogen about her personal experience of living with IBD, how it has influenced her career path and how new research from the Wellcome Sanger Institute brings her hope.
Sanger Science
1 July 2026Red, itchy, unpredictable – eczema is more than just a skincare issue. It is a chronic inflammatory condition that affects people’s day-to-day lives. We explore what it is, what remains unclear and how researchers at the Wellcome Sanger Institute are getting beneath the surface to find out more.
Sanger Life
- 7 July 2026
Dr Joe Christopher, clinician scientist in Dr Raheleh Rahbari’s team at the Wellcome Sanger Institute, is contributing to efforts to uncover cancer at its earliest stages – guided by patients, driven by curiosity and built on the belief that the biggest breakthroughs come from working together.
Innovation
- 26 May 2026
In the latest installment of our innovator blog series, we caught up with Dr Matthew Coelho, Cancer Research UK Career Development Fellow at the Wellcome Sanger Institute. Matthew works within the Somatic Genomics programme and is co-founder of BASE Rx alongside Group Leader, Dr Mathew Garnett.
